Eli Lilly & Co. $LLY, a prominent name in the pharmaceutical industry, has witnessed a remarkable increase in sales for its weight-loss and diabetes medication, Mounjaro, within the Indian market. The month of May marked a significant 60% growth in comparison to April, reflecting the product's acceptance and burgeoning demand in the South Asian region. India ranks third globally in terms of obesity prevalence, positioning itself as a crucial market for Eli Lilly's innovative treatment.